Haemonetics Corp. (HAE) Misses Q2 EPS Views; Guides Soft FY11 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures dip after AI rout, telecoms slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $116.16 --0%
Revenue Growth %: +5.6%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +5.6%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.72, $0.76 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $179.4 million versus the consensus estimate of $173.55 million.
Haemonetics Corp. sees FY2011 EPS of $3.00-$3.10, versus the consensus of $3.38.
Haemonetics Corp. sees FY2011 EPS of $3.00-$3.10, versus the consensus of $3.38.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Express (AXP) Tops Q3 EPS by 84c, Misses on Revenue, Raises FY Guidance
- Cass Information Systems (CASS) Tops Q3 EPS by 1c
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
